Free Trial

enVVeno Medical (NVNO) Competitors

enVVeno Medical logo
$3.48 +0.06 (+1.61%)
As of 10:52 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NVNO vs. CERS, TCMD, NVRO, OSUR, DRTS, RCEL, NYXH, CATX, SKIN, and BWAY

Should you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include Cerus (CERS), Tactile Systems Technology (TCMD), Nevro (NVRO), OraSure Technologies (OSUR), Alpha Tau Medical (DRTS), AVITA Medical (RCEL), Nyxoah (NYXH), Perspective Therapeutics (CATX), Beauty Health (SKIN), and BrainsWay (BWAY). These companies are all part of the "surgical & medical instruments" industry.

enVVeno Medical vs.

Cerus (NASDAQ:CERS) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, community ranking, earnings, dividends, analyst recommendations, valuation and profitability.

enVVeno Medical has lower revenue, but higher earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cerus$185.14M1.26-$37.49M-$0.10-12.25
enVVeno MedicalN/AN/A-$23.52M-$1.18-2.94

Cerus currently has a consensus target price of $3.50, suggesting a potential upside of 185.71%. Given Cerus' stronger consensus rating and higher probable upside, research analysts clearly believe Cerus is more favorable than enVVeno Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cerus
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
enVVeno Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

78.4% of Cerus shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 3.4% of Cerus shares are held by company insiders. Comparatively, 16.0% of enVVeno Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cerus has a beta of 1.58, suggesting that its stock price is 58% more volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500.

Cerus received 414 more outperform votes than enVVeno Medical when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 62.65% of users gave enVVeno Medical an outperform vote.

CompanyUnderperformOutperform
CerusOutperform Votes
570
72.34%
Underperform Votes
218
27.66%
enVVeno MedicalOutperform Votes
156
62.65%
Underperform Votes
93
37.35%

enVVeno Medical has a net margin of 0.00% compared to Cerus' net margin of -11.60%. Cerus' return on equity of -40.55% beat enVVeno Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Cerus-11.60% -40.55% -11.12%
enVVeno Medical N/A -48.72%-45.96%

In the previous week, Cerus had 2 more articles in the media than enVVeno Medical. MarketBeat recorded 2 mentions for Cerus and 0 mentions for enVVeno Medical. Cerus' average media sentiment score of 0.84 beat enVVeno Medical's score of 0.44 indicating that Cerus is being referred to more favorably in the media.

Company Overall Sentiment
Cerus Positive
enVVeno Medical Neutral

Summary

Cerus beats enVVeno Medical on 13 of the 17 factors compared between the two stocks.

Get enVVeno Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVNO vs. The Competition

MetricenVVeno MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$60.94M$4.39B$5.31B$8.28B
Dividend YieldN/A43.63%5.20%4.10%
P/E Ratio-2.6928.8826.7319.58
Price / SalesN/A70.38387.44119.65
Price / CashN/A51.0838.2534.62
Price / Book1.006.156.744.47
Net Income-$23.52M$67.60M$3.23B$248.22M
7 Day Performance-4.01%-2.00%-0.05%-1.32%
1 Month Performance30.15%15.08%8.51%10.73%
1 Year Performance-29.51%21.46%18.25%8.40%

enVVeno Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVNO
enVVeno Medical
0.7363 of 5 stars
$3.48
+1.6%
N/A-30.9%$60.94MN/A-2.6919Positive News
CERS
Cerus
2.8812 of 5 stars
$1.30
-3.7%
$3.50
+169.2%
-35.2%$248.51M$185.14M-11.82290
TCMD
Tactile Systems Technology
3.3288 of 5 stars
$9.98
+2.7%
$16.00
+60.3%
-24.1%$232.02M$293.16M14.26980Positive News
NVRO
Nevro
0.2018 of 5 stars
$5.85
+0.1%
$5.36
-8.3%
-40.4%$224.32M$408.52M-3.091,090
OSUR
OraSure Technologies
4.0213 of 5 stars
$2.66
-0.4%
$5.00
+88.0%
-49.1%$206.12M$185.83M17.73840Gap Down
DRTS
Alpha Tau Medical
1.9741 of 5 stars
$2.80
flat
$8.00
+185.7%
+10.7%$197.07MN/A-6.5180Earnings Report
RCEL
AVITA Medical
1.2515 of 5 stars
$7.34
+1.2%
$17.25
+135.0%
-25.0%$194.03M$64.25M-3.07130Positive News
NYXH
Nyxoah
2.952 of 5 stars
$5.69
-4.8%
$14.50
+154.8%
-19.1%$193.80M$4.52M-3.04110Gap Down
CATX
Perspective Therapeutics
3.4143 of 5 stars
$2.58
+2.8%
$12.75
+394.2%
-83.2%$191.05M$1.43M0.0070News Coverage
Analyst Revision
SKIN
Beauty Health
0.3748 of 5 stars
$1.47
-16.5%
$1.42
-3.6%
-34.5%$184.11M$322.47M-3.501,030
BWAY
BrainsWay
3.7113 of 5 stars
$9.60
+8.7%
$14.25
+48.4%
+90.7%$181.17M$41.02M96.01120Positive News

Related Companies and Tools


This page (NASDAQ:NVNO) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners